Literature DB >> 6832095

Modifying factors in urinary bladder carcinogenesis.

N Ito, S Fukushima, T Shirai, K Nakanishi, R Hasegawa, K Imaida.   

Abstract

N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN) is a potent carcinogen in the urinary bladder of animals. The BBN model of bladder cancer is an excellent model of human urinary bladder cancer and has already led to a greater knowledge of its pathogenesis. In our studies, histogenesis and morphological characteristics of BBN urinary bladder cancer were analyzed in different animal species such as rats, mice, hamsters and guinea pigs and also in different rat strains. Papillary or nodular hyperplasia (PN hyperplasia) is found to be a preneoplastic lesion of the rat urinary bladder. Therefore, the promoting and inhibitory effects of various chemicals in two-stage urinary bladder carcinogenesis were judged by measuring PN hyperplasia in rats. Dose-dependent and organ-specific effects of the urinary bladder promoter, saccharin, in the induction of PN hyperplasia were shown in rats after initiation by BBN. The promoting effect of saccharin was seen more clearly in the urinary bladder of rats after potent initiation. A strain difference in susceptibility of the urinary bladder to the promoter was also shown. These results suggest that the above various factors may also have modifying activities on urinary bladder carcinogenesis in man.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832095      PMCID: PMC1569132          DOI: 10.1289/ehp.8349217

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.

Authors:  M Tatematsu; Y Miyata; M Mizutani; M Hananouchi; M Hirose
Journal:  Gan       Date:  1977-04

2.  Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.

Authors:  H Tsuda; Y Miyata; G Murasaki; H Kinoshita; S Fukushima
Journal:  Gan       Date:  1977-04

3.  Effect of various carcinogenic and non-carcinogenic substances on development of bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosoamine.

Authors:  N Ito; K Matayoshi; K Matsumura; A Denda; T Kani
Journal:  Gan       Date:  1974-04

4.  Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.

Authors:  N Ito; Y Hiasa; A Tamai; E Okajima; H Kitamura
Journal:  Gan       Date:  1969-08

5.  Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine.

Authors:  S Fukushima; M Hirose; H Tsuda; T Shirai; K Hirao
Journal:  Gan       Date:  1976-02

6.  Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.

Authors:  S Fukushima; G H Friedell; J B Jacobs; S M Cohen
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

7.  Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats.

Authors:  S M Cohen; S Fukushima; H Tsuda; G Murasaki; N Ito
Journal:  Gan       Date:  1978-12

8.  Inhibitory effect of 4,4'-diaminodiphenylmethane on liver, kidney and bladder carcinogenesis in rats ingesting N-ethyl-N-hydroxyethylnitrosamine or N-butyl-N-(4-hydroxybutyl) nitros-amine.

Authors:  S Fukushima; M Hirose; A Hagiwara; R Hasegawa; N Ito
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

9.  Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  K Nakanishi; A Hagiwara; M Shibata; K Imaida; M Tatematsu; N Ito
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

10.  Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  G Murasaki; Y Miyata; K Babaya; M Arai; S Fukushima; N Ito
Journal:  Gan       Date:  1980-06
  10 in total
  3 in total

1.  A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma.

Authors:  Carl-Jørgen Arum; Yosuke Kodama; Natale Rolim; Marius Widerøe; Endre Anderssen; Trond Viset; Marit Otterlei; Steinar Lundgren; Duan Chen; Chun-Mei Zhao
Journal:  World J Urol       Date:  2010-04-08       Impact factor: 4.226

2.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

3.  Organ-specific modification of tumor development by low-dose combinations of agents in a rat wide-spectrum carcinogenesis model.

Authors:  S Fukushima; M A Shibata; M Hirose; T Kato; M Tatematsu; N Ito
Journal:  Jpn J Cancer Res       Date:  1991-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.